Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-11
2006-04-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S218000, C514S253040, C540S454000, C540S490000
Reexamination Certificate
active
07026309
ABSTRACT:
A fused bicyclic pyridine derivative represented by the following general formula (1), or a salt thereof:wherein the rings A and B are each a benzene ring, which may have 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring) that are each independently selected from the group consisting of a halogen atom, a substituted or unsubstituted C1to C6alkyl group, and a substituted or unsubstituted C1to C6alkoxyl group;R is a C1to C6alkylsulfonyl group, a C1to C6alkylcarbonyl group, a C1to C6alkoxycarbonyl group, or a formyl group;m is 1 or 2;n is 2 or 3; andq is 1 or 2.
REFERENCES:
patent: 6147071 (2000-11-01), Natsugari et al.
patent: 652218 (1995-05-01), None
patent: WO 97/24356 (1997-07-01), None
Ikeda Makoto
Izawa Shigeru
Seto Shigeki
Tanioka Asao
Kifle Bruck
Kyorin Pharmaceutical Co. Ltd.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Fused bicyclic pyridine derivative as tachykinin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused bicyclic pyridine derivative as tachykinin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic pyridine derivative as tachykinin receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3529413